[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letters
July 11, 2007

Algorithms for Assessing Cardiovascular Risk in Women

JAMA. 2007;298(2):175-178. doi:10.1001/jama.298.2.177-a

To the Editor: Dr Ridker and colleagues1 assessed 35 blood-based biomarkers and traditional epidemiological risk factors to develop a new risk algorithm. It appears that no natriuretic peptide was tested for inclusion in this model. Natriuretic peptides have been shown to predict cardiovascular outcomes in multiple populations, including men and women in the general population and older adults.25 It would be of interest to see how the addition of either B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide might affect their proposed models for cardiovascular risk assessment in women.

First Page Preview View Large
First page PDF preview
First page PDF preview
×